Ts. Loy et al., DISTRIBUTION OF CA 19-9 IN ADENOCARCINOMAS AND TRANSITIONAL-CELL CARCINOMAS - AN IMMUNOHISTOCHEMICAL STUDY OF 527 CASES, American journal of clinical pathology, 99(6), 1993, pp. 726-728
To determine the distribution of CA 19-9 in adenocarcinomas and transi
tional cell carcinomas, formalin-fixed paraffin-embedded tissue from 5
27 cases of these tumors was studied using a monoclonal antibody to CA
19-9 and an avidin-biotin immunohistochemical technique. Positive rea
ctivity was seen in some tumors of all types except hepatocellular car
cinoma. Positive reactions were most common in pancreatic adenocarcino
mas (94%), bile duct carcinomas (91%), and transitional cell carcinoma
s (76%). The majority of tumors from the ovary, endometrium, distal es
ophagus/stomach, and colon also showed positive staining. Immunoreacti
vity was seen in 25-29% of carcinomas of the lung, thyroid, and endoce
rvix. Few positive reactions were seen in renal cell carcinomas (2%),
prostatic adenocarcinomas (3%), and breast carcinomas (6%). It was con
cluded that CA 19-9 is frequently present in several types of adenocar
cinoma and transitional cell carcinoma. Immunostaining for CA 19-9 may
be helpful in excluding hepatocellular carcinoma, prostatic adenocarc
inoma, and renal cell carcinoma in certain clinical settings.